Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Uniqure NV (NASDAQ:QURE)

25.75
Delayed Data
As of Jul 31
 +0.29 / +1.14%
Today’s Change
9.00
Today|||52-Week Range
35.50
+73.87%
Year-to-Date
No recent news for Uniqure NV.

Today’s Trading

Previous close25.46
Today’s open25.50
Day’s range25.30 - 26.71
Volume234,184
Average volume (3 months)257,729
Market cap$545.6M
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)-41.98%
Earnings growth (this year)--
Earnings growth (next 5 years)-26.60%
Revenue growth (last year)+59.05%
P/E ratio--
Price/Sales40.80
Price/Book8.83

Competitors

 Today’s
change
Today’s
% change
AEGRAegerion Pharmaceuti...+0.16+0.84%
CYADCelyad SA-0.29-0.52%
XBITXBiotech Inc+0.14+0.76%
FPRXFive Prime Therapeut...+0.44+1.91%
Data as of 3:59pm ET, 07/31/2015

Financials

Next reporting dateSeptember 1, 2015
EPS forecast (this quarter)$0.04
Annual revenue (last year)$6.2M
Annual profit (last year)-$49.1M
Net profit margin-790.61%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Jörn Aldag
Chief Operating Officer
Eric Goossens
Corporate headquarters
Amsterdam, Noord-holland

Forecasts